Merck, Upsher-Smith to pay $60 mln in 'pay-for-delay' drug case

Merck, Upsher-Smith to pay $60 mln in 'pay-for-delay' drug case


Merck & Co Inc and Upsher-Smith Laboratories Inc have agreed to pay $60.2 million to resolve a lawsuit that said they entered into a deal to unlawfully delay the availability of generic versions of potassium supplement K-Dur. The settlement, disclosed in papers filed in federal court in Newark, New Jersey on Monday, came in a class action filed in 2001 arising out of a settlement in patent litigation between Upsher-Smith and Schering-Plough Corp, now owned by Merck.



from Biotech News